L&T snaps up mega $1.7bn QatarEnergy LNG contract
India's top engineering and construction conglomerate Larsen & Toubro (L&T) has announced that its key unit - L&T Energy Hydrocarbon (LTEH) - has secured a ultra mega contract from QatarEnergy LNG for the North Field Production Sustainability Offshore Compression Project (NFPS COMP 4).
Confirming the mega win, L&T said the contract, which is worth more than Rs150 billion ($1.7 billion), is the largest single order ever received by the company.
The scope of work encompasses the engineering, procurement, fabrication, installation, and commissioning of two offshore compression complexes, each comprising large offshore platforms with compression and power generation facilities, living quarters, flare platforms, interconnected bridges, and other associated structures to be located 80 km off the northeast coast of Qatar.
S N Subrahmanyan, Chairman & Managing Director - L&T, said: "Securing QatarEnergy LNG's ultra mega offshore contract - the largest single order in our history, is a landmark achievement. This prestigious project strengthens our global energy portfolio while supporting Qatar's energy security objectives."
"I thank QatarEnergy LNG for placing their trust in L&T to deliver this complex and strategically important project. We look forward to setting new benchmarks in project execution that will reinforce Qatar's position as a global LNG leader," he stated.
Subramanian Sarma, Deputy Managing Director & President - L&T, said: "The award of a project of such nature is a reflection of the confidence and trust placed by QatarEnergy LNG in L&T's expertise and its ability to deliver such large-scale projects for which L&T is very thankful."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Tribune
3 days ago
- Daily Tribune
New hope for patients with less common breast cancer
A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't seen major drug advances in over a decade, researchers reported Monday. Results from the study, presented at the annual meeting of the American Society for Clinical Oncology, are expected to be submitted to regulators and could soon establish a new firstline therapy for people with HER2-positive metastatic breast cancer -- the advanced stage of a form that comprises 15–20% of all breast cancer cases. HER2-positive cancers are fueled by an overactive HER2 gene, which makes too much of a protein called human epidermal growth factor receptor 2 that helps cancer cells grow and spread. Patients with HER2-positive breast cancer that has spread to other parts of the body live around five years. 'Seeing such a striking improvement was really impressive to us -- we were taking a standard and almost doubling how long patients could have their cancer controlled for,' oncologist Sara Tolaney, chief of the breast oncology division at Dana-Farber Cancer Institute, told AFP. The current standard of care, known as THP, combines chemotherapy with two antibodies that block growth signals from the HER2 protein. The new approach uses a drug called trastuzumab deruxtecan (T-DXd), an antibody attached to a chemotherapy drug. 'Smart bomb' This 'smart bomb' strategy allows the drug to target cancer cells directly. 'You can bind to the cancer cell and dump all that chemo right into the cancer cells,' explained Tolaney. 'Some people call them smart bombs because they're delivering chemo in a targeted fashion -- which is how I think we're able to really increase efficacy so much.' Common side effects included nausea, diarrhea and a low white blood cell count, with a less common effect involving lung scarring. T-DXd is already approved as a 'second-line' option -- used when first-line treatments stop working. But in the new trial, it was given earlier, paired with another antibody, pertuzumab. In a global trial led by Tolaney, just under 400 patients were randomly assigned to receive T-DXd in combination with pertuzumab, thought to enhance its effects. A similar number received the standard THP regimen. A third group, who received T-DXd without pertuzumab, was also enrolled -- but those results haven't yet been reported. 44 percent risk reduction At a follow-up of 2.5 years, the T-DXd and pertuzumab combination reduced the risk of disease progression or death by 44% compared to standard care. Fifteen percent of patients in the T-DXd group saw their cancer disappear entirely, compared to 8.5% in the THP group. Because this was an interim analysis, the median progression-free survival -- meaning the point at which half the patients had seen their cancer return or worsen -- was 40.7 months with the new treatment, compared to 26.9 months with the standard, and could rise further as more data come in. Tolaney said the results would be submitted to regulators around the world, including the US Food and Drug Administration, and that future work would focus on optimizing how long patients remain on the treatment, particularly those showing complete remission. 'This represents a new firstline standard treatment option for HER2-positive metastatic breast cancer,' said Dr. Rebecca Dent, a breast cancer specialist at the National Cancer Center Singapore who was not involved in the study.
Trade Arabia
25-04-2025
- Trade Arabia
L&T emerges lowest bidder for 400kV Kuwait solar project
Kuwait's Ministry of Electricity, Water, and Renewable Energy has announced that Larsen & Toubro (L&T) has emerged as the lowest bidder for its Al Shaqaya Solar Power Generation Station 400 kV Overhead Transmission Line (OHTL) project. The leading Indian construction and engineering conglomerate had set a bid value of KD41.45 million ($135.2 million) for the project. An innovative development, the Shagaya Renewable Energy Project, is being developed by the Kuwait Institute for Scientific Research (KISR). It aims to link the Al Shaqaya solar power station to the main substation in Al Wafra (Z) through the installation of a 400 kV OHTL. In the first phase, the project aims to generate approximately 3.2GW of electricity using renewable sources by 2030, it added.- TradeArabia News Service
Trade Arabia
03-04-2025
- Trade Arabia
L&T unit wins large GCC power infrastructure orders
India's top engineering and construction conglomerate Larsen & Toubro (L&T) has announced that one of its key subsidiaries - Power Transmission & Distribution (PT&D) - has secured large power infrastructure orders from its prime GCC markets of Saudi Arabia, UAE, Qatar and Oman. Unveiling the details, L&T said the contracts snapped up by its Power Transmission & Distribution (PT&D) unit are valued in the range of Rs25 billion to Rs50 billion ($292 million to $584 million). In Saudi Arabia, the vertical will be setting up two 380kV overhead lines for ensuring reliable power supply to the key townships around Riyadh. The combined length of these transmission lines runs over 130 km long. Also, the PT&D unit secured turnkey orders for construction, supply, installation, testing and commissioning of two 132/11kV Gas Insulated Substations (GIS) in the UAE and for a 132kV GIS in Qatar. Further to this, additional orders have been received in ongoing projects in India and Oman, it stated. In India, the PT&D unit won an order for setting up a 765kV GIS in western India and another order for the turnkey construction of a transmission line associated with evacuation of power in the same region.
